SHIKARI® Q-CET


Enzyme immunoassay for the quantitative determination of free Cetuximab (Erbitux®) in serum and plasma.

The Matriks Biotek Shikari® Cetuximab ELISA has been especially developed for the quantitative analysis of free Cetuximab in serum and plasma samples.



Click the diagram to see bigger

about-me





Required Volume (µl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Dedection Limit (ng/mL) 0,1
Spike Recovery (%) 93
Shelf Life (year) 1

SHIKARI® S-ATC


Enzyme immunoassay for the qualitative determination of free Infliximab (Remsima®) in serum and plasma.

Cetuximab (Erbitux®) was associated to the development of anti- Cetuximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Erbitux®. This might lead to severe complications. The Matriks Biotek SHIKARI® Antibody to Cetuximab ELISA Kit can be efficiently used for monitoring anti- Cetuximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Cetuximab antibodies.





Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Dedection Limit (ng/mL) + / -
Spike Recovery (%) -
Shelf Life (year) 1

SHIKARI® S-ATCv2


Enzyme immunoassay for the quantitative determination of antibodies to cetuximab (Erbitux®) in serum and plasma

Cetuximab (Erbitux®) was associated to the development of anti- Cetuximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Erbitux®. This might lead to severe complications. The Matriks Biotek SHIKARI® Antibody to Cetuximab ELISA Kit can be efficiently used for monitoring anti- Cetuximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Cetuximab antibodies.


Click the diagram to see bigger

about-me




Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Dedection Limit (ng/mL) 30
Spike Recovery (%) 97
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Email: info@matriksbiotek.com
Fax: +90 (312) 485 11 87